Martin R. Collyer is a global healthcare executive and qualified accountant (FCCA) with a proven track record of driving operational excellence, revenue growth, and patient engagement across pharmaceutical, biotech, CRO, and health-technology organizations. He has scaled global operations, led product innovation in digital health, and integrated emerging technologies — including generative AI and advanced data analytics — to enhance patient outcomes and commercial performance.
As a Senior Partner at The Bracken Group, Martin leads high-profile consulting engagements spanning patient engagement, biostatistics and data science, digital health innovation, and commercial strategy. He has partnered with global pharmaceutical clients on AI-driven analysis of radiopharmaceutical literature, assessed FDA benefit-risk guidance to shape patient-centric development strategies, and directed due diligence and product positioning for new eClinical solutions. Earlier leadership roles at IQVIA, Bayer Healthcare, Bioclinica (now Clario), Hitachi Data Systems, and MediciGlobal built deep expertise in patient recruitment and retention, operations, and go-to-market growth.
A recognized thought leader and keynote speaker on digitizing the patient experience, Martin blends a CFO’s financial discipline with hands-on operational leadership — helping clients turn data-driven innovation into measurable clinical and commercial results.
Direct-to-patient outreach, recruitment and retention strategy, patient personas and journeys, and therapeutically aligned engagement across oncology, neurology, respiratory, and women’s health.
Digital patient-experience platforms, wearables and remote data capture, and applied generative AI and analytics to improve patient outcomes and trial efficiency.
Global team building and operational realignment — driving efficiency gains, cost reduction, and revenue growth across clinical research and health-technology organizations.
Go-to-market strategy, competitive/SWOT/PESTLE analysis, business development, and commercial positioning for emerging clinical-trial technologies.
Integrating pharmacy, CRM, and EHR data with hotspot and feasibility modeling to identify viable studies, target outreach, and shorten study timelines.
Digital-landscape assessment, capability-gap and M&A target identification, and business transformation to drive long-term strategic growth.
Vendor qualification and SOP authoring, plus partnership management with wearable-technology, CRO, and pharmaceutical organizations.
CFO-level financial management, EBITDA improvement, budgeting, and financial oversight of patient-recruitment and operations portfolios.
Bring Martin’s patient engagement, digital health, and commercial strategy expertise to your next program. Let’s discuss your project.
Work with Martin →
